Ridgewood, NJ, United States of America

Ray Diflaco


Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ray Diflaco: Innovator in Pharmaceutical Composition

Introduction

Ray Diflaco is a notable inventor based in Ridgewood, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in developing abuse-resistant medications. His innovative work aims to enhance patient safety while providing effective pain management solutions.

Latest Patents

Ray Diflaco holds a patent for "Abuse resistant forms of extended release oxycodone, method of use, and method of making." This patent describes an abuse-resistant oral pharmaceutical composition that includes a barrier layer made of a first polymer and a diffusion layer made of a second polymer. The diffusion layer is designed to release the drug in a controlled manner within the gastrointestinal tract. The invention also includes methods for making and using this composition, which is crucial for addressing the opioid crisis.

Career Highlights

Ray Diflaco has dedicated his career to advancing pharmaceutical technologies. His work at Inspirion Delivery Sciences, LLC has positioned him as a leader in the development of safer medication formulations. With a focus on innovation, he continues to explore new ways to improve drug delivery systems.

Collaborations

Ray has collaborated with various professionals in the pharmaceutical industry, including his coworker Manish S Shah. Their combined expertise has contributed to the successful development of new pharmaceutical solutions.

Conclusion

Ray Diflaco's contributions to the field of pharmaceuticals, particularly through his patent for abuse-resistant oxycodone, highlight his commitment to improving patient safety and drug efficacy. His work continues to influence the industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…